Lytix Biopharma AS reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported revenue was NOK 5.13 million compared to NOK 1.62 million a year ago. Net loss was NOK 18.58 million compared to NOK 29.2 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.72 NOK | -1.04% | +7.92% | +17.70% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+17.70% | 20.75M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- LYTIX Stock
- News Lytix Biopharma
- Lytix Biopharma AS Reports Earnings Results for the Fourth Quarter Ended December 31, 2023